3D Bioprinters Market - Industry Size, Growth & Forecast 2028

Summary
Table Of Content

Market Insights

This report on the global 3D bioprinters market studies various technologies used for specific applications in the field of healthcare. Bioprinters help to replicate human organs, and the long-term goal is to create a whole organ with this technology. However, this technology is in its primitive stage, and as the system is developing, it is slowly being accepted in the mainstream medical field.

For this study, the technology segments studied include syringe-based 3D bioprinters, laser-based 3D bioprinters, magnetic levitation 3D bioprinters, inkjet-based 3D bioprinters, and valve-based 3D bioprinters. Market size estimates and forecasts for these segments for 2013 to 2022 are provided in terms of USD Mn and the respective CAGRs for 2016 to 2022, considering 2015 as the base year.

In terms of application type, the global 3D printers market is studied to understand the market maturity and distribution of the market shares. The application segment is further categorized into tissue and organ generation, pharmaceuticals, prosthetics and implants, biosensors, and others (food and animal products & personal product testing). This report shows the market size and forecast segments from 2013 to 2022 and their compounded annual growth rates for 2016 to 2022. The geographic segmentation of the global 3D bioprinters market is performed for North America, Europe, Asia Pacific, and the Rest of the world.

3D Bioprinters are considered a significant innovation for the healthcare industry due to their multiple applications that are expected to bring cost-efficiency and high precision to the several processes carried out in the healthcare industry.

Based on the applications, the 3D bioprinters market is segmented into:

Tissue and Organ Generation
Pharmaceutical
Prosthetics and Implants
Biosensors
Others

Pharmaceuticals are the primary application of 3D printers because the drug development field in today’s world is highly focused on side effects, improving treatment outcomes, and deserting the ‘one-size-fits-all’ approach to medication management. For example, in 2015, the US FDA approved the world’s first 3D printed pill, ‘Spritam levetiracetam’ for treating epileptic seizures. Thus, in the near future, printed human tissues or organs will also help test a drug without using animals and lead to a cruelty-free approach.

The 3D bioprinters market comprises various technologies such as syringe-based 3D bioprinting, laser-based 3D bioprinting, magnetic levitation 3D bioprinting, inkjet-based 3D bioprinting, and valve-based 3D bioprinting.

Syringe-based, laser-based, magnetic levitation, inkjet-based, and valve-based 3D bioprinting are the primary 3D bioprinting techniques analyzed for these studies. Among these, syringe-based 3D bioprinting is the largest segment and is anticipated to maintain its lead during the forecast period. Syringe-based 3D bioprinting has a promising future in regenerative medicine, particularly in organ and tissue reconstruction, as studies show that this technology can generate the intra-organ branched vascular tree. In addition, the wide range of related bioprinters available in the market, along with their proven efficiency in delivering breakthrough outcomes in the promising field of organ and tissue regeneration, supports the growth of this segment.

For this study, the global 3D bioprinters market is categorized into:

North America
Europe
Asia Pacific
Rest of the World

In 2015, North America was observed as the largest market for 3D bioprinters. Large-scale research and academic studies being conducted in the U.S. for further exploring the fullest potential of 3D bioprinting majorly drive the North American 3D bioprinters market. In addition, many research initiatives in regenerative medicine and academic studies on novel drug development and biotechnology are the prime characteristics of the market that demand the use of the latest bioprinting techniques. On the other hand, Asia-Pacific is the fastest developing regional market for 3D bioprinters. Countries such as Japan, China, and Singapore are the most incredible trendsetters in the region. Burgeoning adoption of technological innovations and more significant investments in research and development activities are the major characteristics of the Asia Pacific market. The rapid development of healthcare and biotechnology infrastructure and the growing scope for research and plot are the prime phenomena driving the 3D bioprinting market in the Asia Pacific.

Chapter 1 Preface
1.1 Report Description
1.1.1 Study Purpose
1.1.2 Target Audience
1.1.3 USP and Key Offerings
1.2 Research Methodology

Chapter 2 Executive Summary
2.1 Global 3D Bioprinters Market Portaiture
2.2 Global 3D Bioprinters Market, by Technology, 2015 (USD Mn)
2.3 Relativity Analysis: Global 3D Bioprinters Market, by Application, 2015 & 2022 (USD Mn)
2.4 3D Bioprinters Market Share, by Geography, 2015 (Value %)

Chapter 3 3D Bioprinters Market: Market Dynamics and Outlook
3.1 Introduction, Facts and Figures
3.2 3D Bioprinters Technology: Future Trends and Applications
3.3 Market Dynamics
3.3.1 Drivers
3.3.1.1 Gap between patients waiting for organ transplant and available organ donors
3.3.1.2 Rising demand for cost-efficient technology in drug development processes
3.3.2 Challenges
3.3.2.1 3D Bioprinters of organs face restriction related to the raw materials applied for printing
3.3.3 Opportunities
3.3.3.1 Prosthetics and Orthopedic implants manufactured with 3D Bioprinters technology is in developed stage
3.4 Attractive Investment Proposition
3.5 Competitive Analysis
3.5.1 Market Share Analysis: 3D Printer Applications in Healthcare, 2015 (Value %)

Chapter 4 Global 3D Bioprinters Market, by Technology
4.1 Preface
4.2 Syringe Based 3D Bioprinters
4.3 Laser Based 3D Bioprinters
4.4 Magnetic Levitation 3D Bioprinters
4.5 Inkjet-Based 3D Bioprinters
4.6 Valve-Based 3D Bioprinters

Chapter 5 Global 3D Bioprinters Market, by Application
5.1 Preface
5.2 Tissue and Organ Generation
5.1 Pharmaceuticals
5.2 Prosthetics and Implants
5.3 Biosensors
5.4 Others (Food and Animal Products Manufacturing and Personal Product Testing)

Chapter 6 Global 3D Bioprinters Market, By Geography
6.1 Preface
6.2 North America
6.3 Europe
6.4 Asia Pacific
6.5 Rest of the World (RoW)

Chapter 7 Company Profiles
7.1 BioBots, Inc.
7.1.1 Business Description
7.1.2 Financial Health and Budget Allocation
7.1.3 Product Portfolio
7.1.4 News Coverage
7.2 TeVido BioDevices, LLC
7.2.1 Business Description
7.2.2 Financial Health and Budget Allocation
7.2.3 Product Portfolio
7.2.4 News Coverage
7.3 3D Dynamic Systems Ltd.
7.3.1 Business Description
7.3.2 Financial Health and Budget Allocation
7.3.3 Product Portfolio
7.3.4 News Coverage
7.4 Rokit, Inc.
7.4.1 Business Description
7.4.2 Financial Health and Budget Allocation
7.4.3 Product Portfolio
7.4.4 News Coverage
7.5 Aspect Biosystems Ltd.
7.5.1 Business Description
7.5.2 Financial Health and Budget Allocation
7.5.3 Product Portfolio
7.5.4 News Coverage
7.6 Cyfuse Biomedical K.K.
7.6.1 Business Description
7.6.2 Financial Health and Budget Allocation
7.6.3 Product portfolio
7.6.4 News Coverage
7.7 Organovo Holdings, Inc.
7.7.1 Business Description
7.7.2 Financial Health and Budget Allocation
7.7.3 Product Portfolio
7.7.4 News Coverage
7.8 Stratasys Ltd.
7.8.1 Business Description
7.8.2 Financial Health and Budget Allocation
7.8.3 Product Portfolio
7.8.4 News Coverage
7.9 3D Systems, Inc.
7.9.1 Business Description
7.9.2 Financial Health and Budget Allocation
7.9.3 Product Portfolio
7.9.4 News Coverage
7.10 Envision TEC
7.10.1 Business Description
7.10.2 Financial Health and Budget Allocation
7.10.3 Product Portfolio
7.10.4 News Coverage
7.11 Other Notable Market Players

List Of Figures

FIG. 1 Global 3D Bioprinters Market, by Technology, 2015 (USD Mn)
FIG. 2 Relativity Analysis: Global 3D Bioprinters Market, by Application, 2015 & 2022 (USD Mn)
FIG. 3 Global 3D Bioprinters Market Share, by Geography, 2015 (Value %)
FIG. 4 Attractive Investment Proposition, Global 3D Bioprinters Market, 2015
FIG. 5 Market Share Analysis: 3D Printer Applications in Healthcare, 2015 (Value %)
FIG. 6 Global Syringe Based 3D Bioprinters Market Revenue, 2013 – 2022 (USD Mn)
FIG. 7 Global Laser Based 3D Bioprinters Market Revenue, 2013 – 2022 (USD Mn)
FIG. 8 Global Magnetic Levitation 3D Bioprinters Market Revenue, 2013 – 2022 (USD Mn)
FIG. 9 Global Inkjet-Based 3D Bioprinters Market Revenue, 2013 – 2022 (USD Mn)
FIG. 10 Global Valve-Based 3D Bioprinters Market Revenue, 2013 – 2022 (USD Mn)
FIG. 11 Global 3D Bioprinters Market in Tissue and Organ Generation Segment, 2013 – 2022 (USD Mn)
FIG. 12 Global 3D Bioprinters Market in Pharmaceuticals Segment, 2013 – 2022 (USD Mn)
FIG. 13 Global 3D Bioprinters Market in Prosthetics and Implants Segment, 2013 – 2022 (USD Mn)
FIG. 14 Global 3D Bioprinters Market in Biosensors Segment, 2013 – 2022 (USD Mn)
FIG. 15 Global 3D Bioprinters Market in Others Segment, 2013 – 2022 (USD Mn)

List of Tables

TABLE 1 Global 3D Bioprinters Market Revenue, by Technology, 2013 – 2022 (USD Mn)
TABLE 2 Global 3D Bioprinters Market Revenue, by Application, 2013 – 2022 (USD Mn)
TABLE 3 Global 3D Bioprinters Market Revenue, by Geography, 2013 – 2022 (USD Mn)
TABLE 4 North America 3D Bioprinters Market Revenue, by Country, 2013 – 2022 (USD Mn)
TABLE 5 Europe 3D Bioprinters Market Revenue, by Country, 2013 – 2022 (USD Mn)
TABLE 6 Asia – Pacific 3D Bioprinters Market Revenue, by Country, 2013 – 2022 (USD Mn)
TABLE 7 Rest of the World 3D Biprinters Market Revenue, by Regions, 2013 – 2022 (USD Mn)

Frequently Asked Questions

What is the size of 3D Bioprinters Market?

The market for 3D Bioprinters is expected to reach XX Bn in 2022.

What is the 3D Bioprinters Market CAGR?

The 3D Bioprinters market is expected to see significant CAGR growth over the coming years, at XX%.

What is the Forecast period considered for 3D Bioprinters Market?

The report is forecasted from 2015-2022.

What is the base year considered for 3D Bioprinters Market?

The base year of this report is 2021.

Who are the major players in this market?

Business Description, Financial Health and Budget Allocation, Product Portfolio, News Coverage, TeVido BioDevices, LLC, Business Description are some of the major players in the global market.

Purchase Options

Single User

$4699

Multi User

$5699

Custom Report

$7699

Request Free Sample

Have a question?

Don’t settle for less – trust Mitul to help you find the best solution.

Call: +91 6232 49 3207

EMAIL MITUL

Report delivery within 24 to 48 hours

– Other Info –

–What people say?-

I am very impressed with the information in this report. The author clearly did their research when they came up with this product and it has already given me a lot of ideas.

Jana Schmidt
CEDAR CX Technologies

– Connect with us –